Stock data
Sunshine Biopharma Inc. (SBFM)
Sunshine Biopharma Inc. (SBFM) reported revenue of US$36.31M and net income of -US$5.98M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$36.31M | US$12.26M | -US$6.23M | -US$5.98M | — |
| 2024 | US$34.87M | US$10.67M | -US$5.81M | -US$5.13M | — |
| 2023 | US$24.09M | US$8.34M | -US$4.79M | -US$4.51M | — |
| 2022 | US$4.35M | US$1.70M | -US$27.00M | -US$26.74M | — |
| 2021 | US$0.23M | US$0.11M | -US$2.44M | -US$12.44M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$9.26M | -US$1.56M | — |
| 2026-03-31 | US$8.09M | -US$1.24M | — |
| 2025-12-31 | US$8.58M | -US$2.14M | — |
| 2025-09-30 | US$9.42M | -US$0.88M | — |
| 2025-06-30 | US$9.41M | -US$1.77M | — |
| 2025-03-31 | US$8.90M | -US$1.18M | — |
| 2024-12-31 | US$9.59M | -US$2.16M | — |
| 2024-09-30 | US$8.44M | -US$1.20M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.